ResMed Inc Cash Flow Conversion Efficiency
ResMed Inc cash flow conversion efficiency. Based on the latest financial reports, ResMed Inc (RMD) has a cash flow conversion efficiency ratio of 0.085x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($554.13 Million) by net assets ($6.49 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of ResMed Inc (1993–2025)
Cash flow conversion efficiency of ResMed Inc from 1993 to 2025. This chart illustrates how ResMed Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View RMD share price today for real-time trading data and today's change.
ResMed Inc Cash Flow Conversion Ratio Explained
ResMed Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
ResMed Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ResMed Inc ranked by their cash flow conversion efficiency. Also see ResMed Inc market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Aristocrat Leisure Ltd
AU:ALL
|
0.177x |
|
Telefonaktiebolaget LM Ericsson (publ)
F:ERCA
|
0.018x |
|
Dover Corporation
NYSE:DOV
|
0.026x |
|
SEVEN+I HLDGS UNSP.ADR1/2
F:S6MA
|
0.073x |
|
Inner Mongolia Yili Industrial Group Co Ltd
SHG:600887
|
0.115x |
|
RYANAIR HLDGS ADR NEW/5
F:RY4D
|
-0.008x |
|
Viking Holdings Ltd
NYSE:VIK
|
0.742x |
|
Willis Towers Watson PLC
NASDAQ:WTW
|
0.096x |
Annual Cash Flow Conversion Efficiency for ResMed Inc (1993–2025)
The table below shows the annual cash flow conversion efficiency of ResMed Inc from 1993 to 2025. Review ResMed Inc free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $5.97 Billion | $1.75 Billion | 0.294x | +1.88% |
| 2024-06-30 | $4.86 Billion | $1.40 Billion | 0.288x | +71.61% |
| 2023-06-30 | $4.13 Billion | $693.30 Million | 0.168x | +60.67% |
| 2022-06-30 | $3.36 Billion | $351.15 Million | 0.104x | -59.07% |
| 2021-06-30 | $2.89 Billion | $736.72 Million | 0.255x | -20.54% |
| 2020-06-30 | $2.50 Billion | $802.25 Million | 0.321x | +45.03% |
| 2019-06-30 | $2.07 Billion | $459.05 Million | 0.222x | -9.68% |
| 2018-06-30 | $2.06 Billion | $505.03 Million | 0.245x | +16.12% |
| 2017-06-30 | $1.96 Billion | $414.05 Million | 0.211x | -34.67% |
| 2016-06-30 | $1.69 Billion | $547.93 Million | 0.323x | +33.92% |
| 2015-06-30 | $1.59 Billion | $383.18 Million | 0.241x | +8.48% |
| 2014-06-30 | $1.76 Billion | $391.27 Million | 0.223x | -11.03% |
| 2013-06-30 | $1.61 Billion | $402.82 Million | 0.250x | +4.94% |
| 2012-06-30 | $1.61 Billion | $383.16 Million | 0.238x | +45.66% |
| 2011-06-30 | $1.73 Billion | $283.19 Million | 0.164x | +11.93% |
| 2010-06-30 | $1.29 Billion | $188.21 Million | 0.146x | -31.76% |
| 2009-06-30 | $1.12 Billion | $238.88 Million | 0.214x | +68.11% |
| 2008-06-30 | $1.08 Billion | $137.84 Million | 0.127x | +30.24% |
| 2007-06-30 | $931.22 Million | $91.11 Million | 0.098x | -27.07% |
| 2006-06-30 | $738.15 Million | $99.03 Million | 0.134x | -10.52% |
| 2005-06-30 | $474.06 Million | $71.08 Million | 0.150x | -29.19% |
| 2004-06-30 | $361.50 Million | $76.54 Million | 0.212x | +2.30% |
| 2003-06-30 | $286.43 Million | $59.28 Million | 0.207x | +12.04% |
| 2002-06-30 | $192.93 Million | $35.64 Million | 0.185x | -37.19% |
| 2001-06-30 | $100.37 Million | $29.52 Million | 0.294x | +36.32% |
| 2000-06-30 | $93.97 Million | $20.27 Million | 0.216x | -15.11% |
| 1999-06-30 | $71.61 Million | $18.20 Million | 0.254x | +89.87% |
| 1998-06-30 | $50.80 Million | $6.80 Million | 0.134x | -37.16% |
| 1997-06-30 | $44.60 Million | $9.50 Million | 0.213x | +137.35% |
| 1996-06-30 | $39.00 Million | $3.50 Million | 0.090x | +270.51% |
| 1995-06-30 | $28.90 Million | $700.00K | 0.024x | -91.52% |
| 1994-06-30 | $5.60 Million | $1.60 Million | 0.286x | -17.14% |
| 1993-06-30 | $2.90 Million | $1.00 Million | 0.345x | -- |
About ResMed Inc
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, h… Read more